# Chromosome Abnormalities: Types, Causes, and Clinical Impact

## Introduction to Chromosome Abnormalities

A chromosome abnormality is any deviation from the normal number or structure of chromosomes in a cell. In humans, the normal diploid complement is 46 chromosomes: 22 pairs of autosomes and one pair of sex chromosomes (XX in females, XY in males). Each chromosome carries hundreds to thousands of genes, and even small structural rearrangements can disrupt gene dosage, break critical coding sequences, or dysregulate gene expression. Chromosome abnormalities are a leading cause of miscarriage, congenital malformations, intellectual disability, and cancer.

Chromosome abnormalities fall into two broad categories. **Numerical abnormalities** involve a change in chromosome number, such as an extra copy of a chromosome or a missing chromosome. **Structural abnormalities** involve rearrangements of chromosomal material, including deletions, duplications, inversions, translocations, and ring chromosomes. Both categories can arise *de novo* (new in an individual) or be inherited from a parent who carries a balanced rearrangement.

The clinical significance of a chromosome abnormality depends on the amount of genetic material gained or lost, the specific genes involved, and the cell type affected. A deletion of a few megabases can be lethal, while a balanced translocation may produce no phenotype in the carrier but cause infertility or recurrent miscarriage due to the production of unbalanced gametes. Understanding the mechanisms that generate these abnormalities and the tools used to detect them is essential for diagnosis, genetic counseling, and therapeutic decision-making.

## Types of Chromosome Abnormalities

### Numerical Abnormalities

Numerical abnormalities are classified as either aneuploidy or polyploidy.

**Aneuploidy** is the gain or loss of one or more individual chromosomes, resulting in a chromosome number that is not an exact multiple of the haploid set. The most common aneuploidies in live births are trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sex chromosome aneuploidies such as 45,X (Turner syndrome) and 47,XXY (Klinefelter syndrome). Monosomy for any autosome is almost always lethal *in utero*; the only viable monosomy in humans is 45,X, and even this is associated with high fetal loss.

Aneuploidy arises primarily from **nondisjunction**, the failure of homologous chromosomes or sister chromatids to separate properly during cell division. The resulting gamete has an abnormal chromosome number; fertilization produces a zygote with trisomy or monosomy. The risk of nondisjunction increases dramatically with maternal age, particularly after age 35, due to age-related deterioration of the meiotic spindle and cohesion proteins that hold homologous chromosomes together.

**Polyploidy** is the presence of three or more complete sets of chromosomes. Triploidy (3n = 69 chromosomes) and tetraploidy (4n = 92 chromosomes) are almost always lethal and account for approximately 10–15% of all spontaneous miscarriages. Triploidy can arise from fertilization of an egg by two sperm (dispermy) or from failure of the egg to extrude the second polar body. Tetraploidy typically results from failure of the first cleavage division in a diploid zygote. Live births with polyploidy are extremely rare and survive only briefly.

### Structural Abnormalities

Structural abnormalities result from chromosome breakage followed by aberrant reunion. The major types are deletions, duplications, inversions, translocations, and ring chromosomes.

**Deletions** involve loss of a chromosomal segment. A **terminal deletion** removes the end of a chromosome; an **interstitial deletion** removes an internal segment. The phenotype depends on the size and gene content of the deleted region. Examples include cri-du-chat syndrome (5p deletion), characterized by a high-pitched cat-like cry, microcephaly, and intellectual disability, and DiGeorge syndrome (22q11.2 deletion), which presents with cardiac defects, immune deficiency, and palatal abnormalities.

**Duplications** are the gain of an extra copy of a chromosomal segment. They can arise from unequal crossing over between homologous chromosomes or from errors in [DNA replication](/blog/guides/dna-replication). Duplications can be tandem (the duplicated segment is adjacent to the original) or displaced (located elsewhere on the same or a different chromosome). Partial trisomy of a chromosomal region often produces milder phenotypes than full trisomy. For example, duplication of the 17p11.2 region causes Charcot-Marie-Tooth disease type 1A, a peripheral neuropathy, whereas deletion of the same region causes hereditary neuropathy with liability to pressure palsies.

**Inversions** occur when a chromosomal segment is excised and reinserted in the opposite orientation. A **paracentric inversion** does not include the centromere; a **pericentric inversion** includes the centromere. Inversions are usually balanced—no genetic material is lost or gained—so carriers are typically phenotypically normal. However, during meiosis, an inverted chromosome forms an inversion loop to pair with its normal homolog. Crossing over within the loop produces recombinant chromatids with duplications and deletions, leading to abnormal gametes and increased risk of miscarriage or offspring with congenital anomalies.

**Translocations** are the exchange of chromosomal segments between non-homologous chromosomes. A **reciprocal translocation** involves a two-way exchange; a **Robertsonian translocation** involves fusion of two acrocentric chromosomes (chromosomes 13, 14, 15, 21, 22) at their centromeres, producing a single metacentric chromosome and loss of the short-arm satellite material. Carriers of balanced translocations are phenotypically normal but may produce unbalanced gametes. The most clinically important Robertsonian translocation is t(14;21), which can cause familial Down syndrome: a carrier parent has a 10–15% risk of having a child with trisomy 21.

**Ring chromosomes** form when breaks occur on both arms of a chromosome and the broken ends fuse, creating a circular structure. The distal fragments are lost, so ring chromosomes are associated with deletions. Ring chromosomes are often unstable during mitosis because sister chromatids can become interlocked, leading to breakage-fusion-bridge cycles and cell death. Ring chromosome 20 syndrome, for example, causes epilepsy and intellectual disability.

## How Chromosome Abnormalities Occur

### Meiotic Nondisjunction

Nondisjunction is the primary mechanism of aneuploidy. During meiosis I, homologous chromosomes pair and form chiasmata, which hold them together until anaphase I. If homologs fail to separate, both chromosomes migrate to the same pole, producing one daughter cell with an extra chromosome and one with a missing chromosome. During meiosis II, sister chromatids fail to separate, producing gametes with an extra chromatid or no chromatid for that chromosome.

The molecular basis of nondisjunction involves the spindle assembly checkpoint, which monitors proper attachment of chromosomes to spindle microtubules. In oocytes, this checkpoint is less stringent than in somatic cells, and it weakens with age. Cohesin proteins that hold sister chromatids together are loaded during fetal development and are not replenished; by the time a woman is in her late 30s, cohesin levels are depleted, increasing the risk of premature sister chromatid separation and nondisjunction.

The consequences of nondisjunction depend on the meiotic stage. Errors in meiosis I produce gametes with two different homologs; errors in meiosis II produce gametes with two copies of the same homolog. Molecular analysis of polymorphic markers can distinguish these events and is used in research on the parental origin of aneuploidy.

### Mitotic Errors

Nondisjunction can also occur during mitosis, producing **somatic mosaicism**: an individual with two or more cell populations with different chromosome complements. Mitotic nondisjunction in early embryonic development can produce a mosaic trisomy, where some cells are trisomic and others are normal. The phenotype is often milder than full trisomy because the normal cells partially compensate.

Mitotic errors also cause **chromosome instability** in cancer. Defects in the spindle assembly checkpoint, kinetochore function, or sister chromatid cohesion lead to frequent missegregation events, generating aneuploid daughter cells. This aneuploidy is a hallmark of most solid tumors and contributes to tumor heterogeneity and drug resistance.

### Chromosomal Breakage and Repair

Structural abnormalities arise from DNA double-strand breaks (DSBs) that are repaired incorrectly. DSBs can be caused by ionizing radiation, certain chemicals, reactive oxygen species, or [replication fork collapse](/knowledge/molecular-biology/replication-fork-collapse). Cells repair DSBs through two main pathways: **non-homologous end joining (NHEJ)** and **[homologous recombination](/knowledge/molecular-biology/homologous-recombination) (HR)**.

NHEJ directly ligates broken ends without requiring a homologous template. It is error-prone and can join ends from different chromosomes, producing translocations. HR uses the sister chromatid or homologous chromosome as a template and is generally error-free, but aberrant HR between non-allelic homologous sequences causes deletions, duplications, and inversions. This mechanism, called **non-allelic [homologous recombination](/knowledge/molecular-biology/homologous-recombination) (NAHR)**, is responsible for many recurrent microdeletion syndromes, such as 22q11.2 deletion syndrome, because the region is flanked by low-copy repeats that misalign during meiosis.

Environmental factors that increase chromosome breakage include ionizing radiation, which causes DSBs directly, and chemotherapeutic agents such as bleomycin and etoposide, which poison topoisomerases and generate DSBs. Certain viruses, including human papillomavirus, can integrate into the host genome and cause chromosomal rearrangements. However, most structural abnormalities arise spontaneously during gametogenesis, and their frequency increases with paternal age due to accumulating mutations in spermatogonial stem cells.

## Clinical Consequences of Chromosome Abnormalities

### Autosomal Abnormalities

Autosomal aneuploidies are the most common clinically recognized chromosome abnormalities. Trisomy 21 (Down syndrome) occurs in approximately 1 in 700 live births and is the most common viable autosomal trisomy. The phenotype includes intellectual disability, characteristic facial features, congenital heart defects (particularly atrioventricular septal defects), and increased risk of Alzheimer disease and acute leukemia. The extra copy of chromosome 21 leads to overexpression of genes such as *DYRK1A*, which contributes to cognitive impairment, and *APP*, which encodes the amyloid precursor protein and underlies the early-onset Alzheimer pathology.

Trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) are much rarer and more severe. Most affected infants die within the first year. Trisomy 18 causes growth restriction, clenched hands with overlapping fingers, and cardiac defects; trisomy 13 causes holoprosencephaly, cleft lip and palate, and polydactyly. The severity reflects the large number of dosage-sensitive genes on these chromosomes.

Structural autosomal abnormalities produce contiguous gene syndromes, where deletion or duplication of a chromosomal region affects multiple genes. For example, the 7q11.23 deletion causes Williams syndrome, characterized by elfin facies, supravalvular aortic stenosis, and a distinctive cognitive profile with strong language skills but poor visuospatial ability. The 15q11-q13 region is subject to [genomic imprinting](/knowledge/molecular-biology/genomic-imprinting); deletion of the maternal copy causes Angelman syndrome, while deletion of the paternal copy causes Prader-Willi syndrome. This parent-of-origin effect is due to [X Chromosome Inactivation](/knowledge/molecular-biology/x-chromosome-inactivation)-like epigenetic silencing, although the mechanism involves imprinting centers rather than X inactivation.

### Sex Chromosome Abnormalities

Sex chromosome abnormalities are generally milder than autosomal abnormalities because of the small number of genes on the Y chromosome and the ability of X-linked genes to be dosage-compensated. Turner syndrome (45,X) occurs in 1 in 2,500 live female births and is characterized by short stature, webbed neck, and ovarian dysgenesis. The phenotype results from haploinsufficiency of *SHOX* (short stature homeobox) and other genes that escape X inactivation.

Klinefelter syndrome (47,XXY) occurs in 1 in 600 live male births and is characterized by tall stature, small testes, azoospermia, and gynecomastia. The extra X chromosome is inactivated, but some genes escape inactivation and are overexpressed. 47,XYY and 47,XXX are usually associated with minimal or no physical abnormalities, although there are increased risks of learning difficulties and behavioral problems.

### Chromosome Abnormalities in Cancer

Cancer is fundamentally a genetic disease, and chromosome abnormalities are central to its pathogenesis. Two classes of genetic changes drive cancer: activation of oncogenes and inactivation of [Tumor Suppressor Gene](/knowledge/molecular-biology/tumor-suppressor-gene)s. Chromosome abnormalities achieve both.

**Reciprocal translocations** can create fusion oncogenes. The classic example is the Philadelphia chromosome, a t(9;22)(q34;q11) translocation that fuses *BCR* on chromosome 22 with *ABL1* on chromosome 9. The resulting BCR-ABL fusion protein has constitutive tyrosine kinase activity, driving chronic myeloid leukemia (CML). The drug imatinib (Gleevec) specifically inhibits BCR-ABL and has transformed CML from a fatal disease to a manageable chronic condition. Other examples include t(8;14) in Burkitt lymphoma, which places *MYC* under the control of the immunoglobulin heavy chain enhancer, and t(15;17) in acute promyelocytic leukemia, which fuses *PML* with *RARA*.

**Deletions** can remove [tumor suppressor genes](/knowledge/molecular-biology/tumor-suppressor-gene). Deletion of 13q14 removes *RB1*, causing retinoblastoma; deletion of 17p13 removes *TP53*, the most frequently mutated [tumor suppressor gene](/knowledge/molecular-biology/tumor-suppressor-gene) in human cancer. Loss of heterozygosity (LOH) at these loci is a key step in tumor progression.

**Aneuploidy** is a hallmark of epithelial cancers. Most solid tumors have highly abnormal chromosome numbers, often with more than 60 chromosomes. This aneuploidy is caused by chromosomal instability (CIN), a defect in chromosome segregation that generates random gains and losses. CIN promotes tumor evolution by generating genetic diversity, allowing selection of cells with growth advantages.

## Methods for Detecting Chromosome Abnormalities

### Karyotyping

Karyotyping is the traditional method for detecting chromosome abnormalities. Cells are cultured, arrested in metaphase with colchicine, and stained with Giemsa to produce a characteristic banding pattern (G-banding). Each chromosome has a unique banding pattern, allowing identification of individual chromosomes and detection of large structural abnormalities (>5–10 Mb). Karyotyping is performed on peripheral blood lymphocytes, bone marrow cells, amniocytes, or chorionic villus samples.

The procedure involves several steps. First, phytohemagglutinin (PHA) is added to stimulate T-lymphocyte division in blood cultures. After 72 hours of culture at 37°C in RPMI 1640 medium supplemented with 10–15% fetal bovine serum, colcemid is added at a final concentration of 0.1 µg/mL to arrest cells in metaphase. Cells are then treated with a hypotonic solution (0.075 M KCl) to swell them, fixed in methanol:acetic acid (3:1), and dropped onto slides. After aging, the slides are treated with trypsin and stained with Giemsa. Typically, 20 metaphase spreads are analyzed, and at least 5 karyotypes are fully characterized.

Karyotyping cannot detect abnormalities smaller than the resolution of the banding pattern, such as microdeletions or subtle rearrangements. It also requires viable, dividing cells, which limits its use in some clinical situations.

### Fluorescence [In Situ Hybridization](/knowledge/molecular-biology/in-situ-hybridization) (FISH)

FISH uses fluorescently labeled DNA probes that hybridize to specific chromosomal regions. The technique can detect numerical and structural abnormalities that are too small for karyotyping. Probes are designed to target specific loci, centromeres, or whole chromosomes.

The FISH procedure involves denaturing the target DNA on a slide, applying the probe, and incubating overnight at 37°C in a humidified chamber. After washing to remove unbound probe, the slide is counterstained with DAPI (4',6-diamidino-2-phenylindole) and examined under a fluorescence microscope. Each probe emits a characteristic signal; the number and location of signals indicate the copy number and arrangement of the target region.

FISH is used for several clinical applications. **Interphase FISH** on uncultured cells can rapidly detect aneuploidies in prenatal samples, such as trisomy 21, 18, and 13, within 24–48 hours. **Locus-specific FISH** detects microdeletions, such as the 22q11.2 deletion in DiGeorge syndrome. **Fusion probes** detect translocations, such as BCR-ABL in CML, using a dual-color, dual-fusion strategy: one probe labels BCR in green and another labels ABL in red; a fusion signal appears yellow. FISH is also used to assess HER2 amplification in breast cancer, guiding treatment with trastuzumab.

### Chromosomal Microarray Analysis

Chromosomal microarray analysis (CMA) detects copy number variants (CNVs) across the entire genome at high resolution. Two platforms are used: **array comparative genomic hybridization (aCGH)** and **single-nucleotide polymorphism (SNP) arrays**. In aCGH, test DNA and normal reference DNA are labeled with different fluorophores and co-hybridized to a microarray containing thousands of oligonucleotide probes. The ratio of test to reference signal at each probe indicates the copy number. SNP arrays detect both copy number and genotype, allowing detection of uniparental disomy and regions of homozygosity.

CMA can detect deletions and duplications as small as 50–100 kb, far below the resolution of karyotyping. It is the first-line test for children with unexplained intellectual disability, developmental delay, or multiple congenital anomalies, detecting a causative abnormality in 15–20% of cases. CMA cannot detect balanced rearrangements, such as reciprocal translocations or inversions, because these do not change copy number.

### Next-Generation Sequencing

Next-generation sequencing (NGS) is increasingly used to detect chromosome abnormalities. **Whole-genome sequencing** can identify structural variants, including translocations and inversions, by analyzing discordant read pairs and split reads. **Low-pass whole-genome sequencing** (0.1–0.5× coverage) can detect aneuploidy and large CNVs from cell-free DNA in maternal blood, forming the basis of non-invasive prenatal testing (NIPT). NIPT detects trisomy 21, 18, and 13 with sensitivity above 99% for trisomy 21, although it is a screening test, not a diagnostic test, and positive results require confirmation by invasive testing.

**Optical genome mapping** is an emerging technology that images long DNA molecules (150 kb–1 Mb) labeled at specific sequence motifs. It can detect structural variants, including balanced translocations and inversions, at high resolution and is being adopted in clinical cytogenetics.

## Common Misconceptions and Pitfalls

Students frequently confuse several concepts when studying chromosome abnormalities.

**Chromosome versus chromatid.** A chromosome is a single DNA molecule with associated proteins. After DNA replication, the chromosome consists of two sister chromatids joined at the centromere. During anaphase, sister chromatids separate, and each becomes an independent chromosome. A common error is to describe a replicated chromosome as two chromosomes before sister chromatid separation; this is incorrect—it is one chromosome with two chromatids.

**Mosaicism versus chimerism.** Mosaicism refers to two or more cell populations with different genotypes arising from a single zygote, typically due to mitotic nondisjunction. Chimerism refers to cell populations derived from two different zygotes, which can occur after fusion of two embryos or after bone marrow transplantation. These are distinct mechanisms with different clinical implications.

**Genotype-phenotype correlation is not linear.** Students often assume that more genetic material always produces a more severe phenotype. This is false. Duplications can be less severe than deletions of the same region because gene dosage effects are not symmetric. Moreover, the phenotype depends on the specific genes involved, not just the size of the abnormality. A small deletion of a critical gene can be more severe than a large deletion of non-essential DNA.

**Balanced does not mean harmless.** A balanced translocation or inversion does not change the amount of genetic material, so the carrier is usually phenotypically normal. However, the carrier is at high risk of producing unbalanced gametes, leading to infertility, recurrent miscarriage, or offspring with congenital anomalies. Genetic counseling must address this reproductive risk.

**Aneuploidy is not always lethal.** While most aneuploidies are lethal *in utero*, some are viable, particularly trisomy 21 and sex chromosome aneuploidies. The viability depends on the number of genes on the chromosome and their dosage sensitivity.

**NIPT is not diagnostic.** Non-invasive prenatal testing is a screening test based on cell-free DNA in maternal blood. It can produce false positives and false negatives, particularly in cases of confined placental mosaicism, maternal copy number variants, or maternal malignancy. Positive NIPT results must be confirmed by amniocentesis or chorionic villus sampling.

## Summary and Study Tips

Chromosome abnormalities are deviations in chromosome number or structure that cause genetic disease. Numerical abnormalities include aneuploidy (trisomy, monosomy) and polyploidy; structural abnormalities include deletions, duplications, inversions, translocations, and ring chromosomes. These abnormalities arise from nondisjunction during meiosis or mitosis, or from incorrect repair of DNA double-strand breaks. Their clinical consequences range from embryonic lethality to viable syndromes with intellectual disability, congenital anomalies, and cancer predisposition. Detection methods include karyotyping, FISH, chromosomal microarray, and next-generation sequencing, each with different resolutions and applications.

To study this material effectively, focus on mechanisms rather than memorizing syndromes. Understand how nondisjunction produces aneuploidy, how NAHR produces microdeletions, and how translocations create fusion oncogenes. Use tables to compare syndromes by chromosome, mechanism, and phenotype. Practice drawing meiotic segregation of a translocation carrier to understand the production of unbalanced gametes. Finally, connect the concepts to clinical cases: a newborn with dysmorphic features, a child with developmental delay, an adult with leukemia—each requires a different diagnostic approach.

## Frequently Asked Questions

### What is a chromosome abnormality?

A chromosome abnormality is any change in the normal number or structure of chromosomes. Numerical abnormalities involve gains or losses of whole chromosomes; structural abnormalities involve rearrangements of chromosomal segments, including deletions, duplications, inversions, translocations, and ring chromosomes.

### What are the types of chromosome abnormalities?

Numerical abnormalities include aneuploidy (trisomy, monosomy) and polyploidy (triploidy, tetraploidy). Structural abnormalities include deletions, duplications, inversions, translocations, and ring chromosomes. Each type has distinct mechanisms and clinical consequences.

### How do chromosome abnormalities occur?

Numerical abnormalities arise from nondisjunction, the failure of chromosomes to separate during meiosis or mitosis. Structural abnormalities arise from DNA double-strand breaks that are repaired incorrectly, often through non-homologous end joining or non-allelic homologous recombination. Environmental factors such as ionizing radiation can increase the frequency of chromosome breakage.

### What is the most common chromosome abnormality?

The most common chromosome abnormality in live births is trisomy 21 (Down syndrome), occurring in approximately 1 in 700 births. However, aneuploidy in general is extremely common in conceptuses; it is estimated that 50–70% of spontaneous miscarriages are due to chromosome abnormalities, with trisomy 16 being the most frequent in miscarriages.

### Can chromosome abnormalities be inherited?

Yes. Balanced translocations and inversions can be inherited from a phenotypically normal carrier parent, who is at increased risk of producing unbalanced gametes. Microdeletions can also be inherited from a parent who carries the deletion in a mosaic state or who has a mild phenotype. However, most aneuploidies arise *de novo* during gametogenesis.

### How are chromosome abnormalities detected?

Chromosome abnormalities are detected by karyotyping (for large abnormalities), FISH (for specific loci), chromosomal microarray (for copy number variants), and next-generation sequencing (for structural variants and aneuploidy). The choice of method depends on the clinical question and the resolution required.

### What is the difference between a chromosome abnormality and a gene mutation?

A chromosome abnormality involves changes at the level of whole chromosomes or large chromosomal segments, affecting many genes at once. A gene mutation is a change in the DNA sequence of a single gene, such as a point mutation, small insertion, or deletion. Gene mutations are typically detected by DNA sequencing, while chromosome abnormalities are detected by cytogenetic or microarray methods. Both can cause disease, but they differ in scale, mechanism, and detection strategy.

## Key Takeaways

- Chromosome abnormalities are classified as numerical (aneuploidy, polyploidy) or structural (deletions, duplications, inversions, translocations, ring chromosomes).
- Nondisjunction in meiosis is the primary cause of aneuploidy; maternal age is the major risk factor.
- Structural abnormalities arise from incorrect repair of DNA double-strand breaks, often via non-homologous end joining or non-allelic homologous recombination.
- Clinical consequences range from embryonic lethality to viable syndromes with intellectual disability and congenital anomalies; balanced rearrangements may be phenotypically silent but cause reproductive risk.
- Chromosome abnormalities are central to cancer pathogenesis, exemplified by the BCR-ABL fusion in chronic myeloid leukemia and deletion of tumor suppressor genes.
- Detection methods include karyotyping, FISH, chromosomal microarray, and next-generation sequencing, each with specific resolutions and clinical applications.
- Understanding the mechanism of an abnormality is more important than memorizing syndrome names; use tables and diagrams to integrate chromosome, mechanism, and phenotype.

## Further Reading

- Okuyama T, Oho Y, Kosuga M. *[Sex chromosome abnormality]*. Ryoikibetsu shokogun shirizu. 2000. [PubMed 11057258](https://pubmed.ncbi.nlm.nih.gov/11057258/)
- ATKINS L, CONNELLY JP. *XXXXY SEX-CHROMOSOME ABNORMALITY*. American journal of diseases of children (1960). 1963. [PubMed 14077170](https://doi.org/10.1001/archpedi.1963.02080050516022)
- BARR ML et al. *The XXXXY sex chromosome abnormality*. Canadian Medical Association journal. 1962. [PubMed 13969480](https://pubmed.ncbi.nlm.nih.gov/13969480/)
- Shen JD et al. *[Chromosome abnormality rate and related factors of spontaneous abortion in early pregnancy]*. Zhonghua fu chan ke za zhi. 2019. [PubMed 31874468](https://doi.org/10.3760/cma.j.issn.0529-567x.2019.12.002)
- Chandley AC. *Infertility and chromosome abnormality*. Oxford reviews of reproductive biology. 1984. [PubMed 6397710](https://pubmed.ncbi.nlm.nih.gov/6397710/)
- Gustavsson I. *Chromosome abnormality in cattle*. Nature. 1966. [PubMed 6007926](https://doi.org/10.1038/211865a0)

## Related Topics

- [Chromosome Structure](/knowledge/molecular-biology/chromosome-structure)
- [Frameshift Mutation](/knowledge/molecular-biology/frameshift-mutation)
- [Genetic Mutation](/knowledge/molecular-biology/genetic-mutation)
- [Newborn Screening](/knowledge/molecular-biology/newborn-screening)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)